NL
DE
Novartis approved a 600K euro grant proposal from Frans Cremers, Susanne Roosing and Alexander Hoischen. To identify individuals with congenital blindness or retinitis pigmentosa due to RPE65 mutations, 4.000 probands from all over the world will be sequenced for mutations in ~100 genes based on the smMIP-target-enrichment technology and the NovaSeq6000 sequencing platform.
Related news items
Finally, an explanation for hearing loss in twelve Dutch families
9 July 2020 The culprit is a genetic abnormality, a discovery that immediately makes it one of the most common causes of hereditary hearing loss in the Netherlands. read more
Online conference offers advantages for scientists
2 July 2020Flying around the world for every congress is outdated. Scientists can now choose for a more environmentally conscious option. Published in 'De Volkskrant', Radboudumc researchers Teun Bousema, Estel Collado and Julie Verhoef argue that the online congress can offer serious advantages.
read more
Cooling strategies for COVID-19 health personnel to attentuate PPE-induced heat strain
11 June 2020 Radboudumc develops infographic with cooling information read more
Study into better protection for healthcare workers against coronavirus infection
19 March 2020 Radboudumc and UMC Utrecht will investigate whether health care workers are better protected against the coronavirus after a vaccination against tuberculosis (BCG vaccine). This vaccine does not directly protect against the coronavirus, but provides a boost to the immune system. read more
Save the date for Radboud New Frontiers 2018: Betere zorg, netwerkzorg?
17 January 2018 After standard care, standardized care, and personalized care, network care will be care 4.0. But how exactly do you do that? Should we create new structures for it or is it just a matter of trust and ability to step back? read more
